Covered recipient · General Payments record
MARGARET ELIZABETH BIRD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2023
$1,493.07
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.65 | 34 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $201.12 | 15 |
| ITI, Inc. | $168.23 | 12 |
| Alkermes, Inc. | $29.29 | 1 |
| Vanda Pharmaceuticals Inc. | $25.55 | 1 |
| Teva Pharmaceuticals USA, Inc. | $24.54 | 1 |
| Axsome Therapeutics, Inc. | $19.76 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.09 | 1 |
| Lundbeck LLC | $15.38 | 1 |
| Indivior Inc. | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.37 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037575 | CMS |
| ABBVIE INC. | $7.10 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037587 | CMS |
| ABBVIE INC. | $15.03 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037599 | CMS |
| ABBVIE INC. | $6.28 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037611 | CMS |
| ABBVIE INC. | $21.47 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037623 | CMS |
| ABBVIE INC. | $7.10 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037635 | CMS |
| ABBVIE INC. | $24.33 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037647 | CMS |
| ABBVIE INC. | $8.41 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037659 | CMS |
| ABBVIE INC. | $26.24 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037671 | CMS |
| ABBVIE INC. | $8.67 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037683 | CMS |
| ABBVIE INC. | $6.88 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037697 | CMS |
| ABBVIE INC. | $11.07 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037709 | CMS |
| ABBVIE INC. | $11.28 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037721 | CMS |
| ABBVIE INC. | $15.55 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037731 | CMS |
| ABBVIE INC. | $13.34 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003037743 | CMS |
| Alkermes, Inc. | $29.29 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022781367 | CMS |
| Axsome Therapeutics, Inc. | $19.76 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056356183 | CMS |
| Indivior Inc. | $14.69 | 05/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034290995 | CMS |
| ITI, Inc. | $11.75 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799441 | CMS |
| ITI, Inc. | $5.79 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799447 | CMS |
| ITI, Inc. | $7.67 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799457 | CMS |
| ITI, Inc. | $97.54 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799463 | CMS |
| ITI, Inc. | $7.71 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799471 | CMS |
| ITI, Inc. | $7.42 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799479 | CMS |
| ITI, Inc. | $7.47 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799487 | CMS |
| ITI, Inc. | $4.00 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799495 | CMS |
| ITI, Inc. | $3.71 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799503 | CMS |
| ITI, Inc. | $2.58 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799513 | CMS |
| ITI, Inc. | $6.10 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799519 | CMS |
| ITI, Inc. | $6.49 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040799528 | CMS |
| Lundbeck LLC | $15.38 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032443949 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.09 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015003323 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.54 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056942925 | CMS |
| Vanda Pharmaceuticals Inc. | $25.55 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051548981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.